Safety and Effectiveness of PCSK9 Inhibitors in Orthotopic Heart Transplant Patients

被引：0

作者：

Sammour, Yasser ^{[1
]}

Austin, Bethany A. ^{[1
]}

Borkon, Michael ^{[1
]}

Everley, Mark P. ^{[1
]}

Fendler, Timothy J. ^{[1
]}

Khumri, Taiyeb M. ^{[1
]}

Lawhorn, Stephanie L. ^{[1
]}

Magalski, Anthony ^{[1
]}

Nassif, Michael E. ^{[1
]}

Vodnala, Deepthi ^{[1
]}

Kao, Andrew C. ^{[1
]}

Sperry, Brett W. ^{[1
]}

机构：

[1] St Lukes Mid Amer Heart Inst, Kansas City, MO USA

来源：

JOURNAL OF CARDIAC FAILURE | 2020年 / 26卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

054

引用

页码：S22 / S22

页数：1

共 50 条

[21] Access to PCSK9 Inhibitors
Baum, Seth J.
Lepor, Norman E.
Robinson, Jennifer G.
REVIEWS IN CARDIOVASCULAR MEDICINE, 2018, 19 : S47 - S50
[22] PCSK9 inhibitors are go
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (09) : 593 - 593
[23] Oral PCSK9 Inhibitors
Anandita Agarwala
Ramsha Asim
Christie M. Ballantyne
Current Atherosclerosis Reports, 2024, 26 : 147 - 152
[24] A SYSTEMATIC REVIEW OF COMPARATIVE EFFECTIVENESS OF EZETIMIBE AND PCSK9 INHIBITORS
Park, T.
Griggs, S.
Henderson, E.
Suh, D.
Lee, S.
VALUE IN HEALTH, 2017, 20 (09) : A614 - A614
[25] Oral PCSK9 Inhibitors
Agarwala, Anandita
Asim, Ramsha
Ballantyne, Christie M.
CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (05) : 147 - 152
[26] PCSK9 inhibitors are go
Asher Mullard
Nature Reviews Drug Discovery, 2015, 14 : 593 - 593
[27] Treatment of Hypercholesterolemia With PCSK9 Inhibitors in Heart Transplant Recipients. First Experience in Spain
del Val Groba-Marco, Maria
del Castillo-Garcia, Samuel
Barge-Caballero, Gonzalo
Barge-Caballero, Eduardo
Couto-Mallon, David
Crespo-Leiro, Maria G.
REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (12): : 1084 - 1086
[28] IMPACT OF PCSK9 INHIBITORS ON HEMOSTASIS IN PATIENTS WITH HYPERCHOLESTEROLEMIA
Basiak, M.
Kosowski, M.
Hachula, M.
Krysiak, R.
Okopien, B.
ATHEROSCLEROSIS, 2023, 379 : S136 - S136
[29] Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia
Tomlinson, Brian
Patil, Nivritti Gajanan
Fok, Manson
Lam, Christopher Wai Kei
ENDOCRINOLOGY AND METABOLISM, 2021, 36 (02) : 279 - 295
[30] Use of PCSK9 Inhibitors in Liver Transplant Recipients: A SingleCenter Review
Potts, M.
Hamel, S.
Rega, S.
Feurer, I. D.
Scanga, A.
AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1186 - S1186

← 1 2 3 4 5 →